Department of Anesthesiology, Magee Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, USA.
Br J Anaesth. 2014 Dec;113 Suppl 2:ii3-8. doi: 10.1093/bja/aeu379.
The concept of rapid delivery of multiple blood products to the bedside of a massively haemorrhaging patient seems to be a logical approach to the management of the massively bleeding patient. However, controversy exists in the use of fixed blood component ratios. Assessing the extent of the coagulopathy through point-of-care testing might provide patients with product administration as needed, and avoid excessive transfusion and its associated complications.
快速将多种血液制品递送至大量出血患者床边的理念似乎是大量出血患者处理的一种合理方法。然而，在固定血液成分比例的使用方面存在争议。通过即时检测评估凝血障碍的程度，可能会按需为患者提供产品输注，并避免过度输血及其相关并发症。
